166 results on '"Huang, Wei-Han"'
Search Results
2. Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies
3. Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies.
4. Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria
5. Recent advancements in hematopoietic stem cell transplantation in Taiwan
6. Effectiveness of Chinese herbal medicine as a complementary treatment for neutropenia prevention and immunity modulation during chemotherapy in patients with breast cancer: study protocol for a real-world pragmatic clinical trial (Preprint)
7. An Ultrathin and Adhesive Skin-Compliant Electrode Patch combined with a Portable Multi-Channel EEG Acquisition System
8. MDS-273 Oral Iptacopan Monotherapy Increases Paroxysmal Nocturnal Hemoglobinuria (PNH) Red Blood Cell Clone Size Via Control of Intra- and Extravascular Hemolysis in Anti-C5-Treated PNH Patients With Anemia
9. POSTER: MDS-273 Oral Iptacopan Monotherapy Increases Paroxysmal Nocturnal Hemoglobinuria (PNH) Red Blood Cell Clone Size Via Control of Intra- and Extravascular Hemolysis in Anti-C5-Treated PNH Patients With Anemia
10. S182: ORAL IPTACOPAN MONOTHERAPY INCREASES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE VIA CONTROL OF INTRA- AND EXTRAVASCULAR HEMOLYSIS IN ANTI-C5-TREATED PNH PATIENTS WITH ANEMIA
11. Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor–mutated lung adenocarcinoma
12. Implementation of Noninvasive Preimplantation Genetic Testing for Aneuploidy with Spent Blastocyst Medium into Clinical and Laboratory Practice: The First Successful Experience in Taiwan
13. Prognostic Factors of Fournier's Gangrene in the Elderly: Experiences of a Medical Center in Southern Taiwan
14. Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot study
15. Carfilzomib Use Among Patients with Relapsed/Refractory Multiple Myeloma in the Asia Pacific Region: Characteristics and Outcomes By Regimen from a Prospective, Real-World Study
16. Cultural difference and visual information on hotel rating prediction
17. Novel Bilayer Composite Membrane for Passive Direct Methanol Fuel Cells with Pure Methanol
18. Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase—Producing Enterobacteriaceae: MIC Matters
19. Conversion of Escherichia coli into Mixotrophic CO 2 Assimilation with Malate and Hydrogen Based on Recombinant Expression of 2-Oxoglutarate:Ferredoxin Oxidoreductase Using Adaptive Laboratory Evolution.
20. Optimization of design and fatigue simulations for an electric assisted bicycle frame using uniform design and grey relational analysis.
21. Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia and their emergence in the community
22. Optimization of design and fatigue simulations for an electric assisted bicycle frame using uniform design and grey relational analysis
23. New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience
24. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
25. Designing a Scoring System for Differential Diagnosis From Reactive Thrombocytosis and Essential Thrombocytosis
26. Capturing Pluripotency and Beyond
27. Thalidomide treatment in a myelofibrosis patient with leukemia transformation
28. Bioinspired assembly of surface-roughened nanoplatelets
29. Multidimensional Flow Cytometry for Detection of Rare Populations in Hematological Malignancies
30. Acute Myeloid Leukemia Transformation from Myelofibrosis Upon Remission of an Orbital Myeloid Sarcoma – A Case Report
31. Robust fuzzy control for discrete perturbed time-delay affine Takagi-Sugeno fuzzy models
32. The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
33. Post-HSCT relapsed precursor B-cell ALL successfully salvaged by BiTE followed by consolidation CAR-T cell therapy: A report of two cases
34. Clinical Experiences with Recombinant Activated Factor VII for Managing Uncontrolled Hemorrhage in Non-Hemophilic Patients
35. Bioinspired Assembly of Inorganic Nanoplatelets for Reinforced Polymer Nanocomposites
36. Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation
37. Higher CD56+ or CD2+ lymphocyte percentage predicts poor steroid response in patients with immune thrombocytopenia
38. The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma.
39. Lower lymphocyte percentage and higher platelet count as poor prognostic factors for patients with epidermal growth factor receptor–mutated lung adenocarcinoma receiving tyrosine kinase inhibitors as first-line treatment
40. Low-Energy Extracorporeal Shock Wave Therapy Ameliorates Kidney Function in Diabetic Nephropathy
41. GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1
42. Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor-mutated lung adenocarcinoma.
43. Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation.
44. Stable Time Reduction by LDO in PWM Switching Buck Converter
45. High rate of invasive fungal infections after non-T cell depleted haploidentical allo-HSCT even under antifungal prophylaxis
46. Processing improvement and performance analysis of La 0.85 Sr 0.15 Ga 0.8 Mg 0.2 O 2.825 electrolyte-supported fuel cells
47. Presence of pleural effusion is associated with a poor prognosis in patients with epidermal growth factor receptor-mutated lung cancer receiving tyrosine kinase inhibitors as first-line treatment
48. Corrigendum to “Prognostic Factors of Fournier's Gangrene in the Elderly: Experiences of a Medical Center in Southern Taiwan” [Int J Gerontol 10 (3) (2016) 151–155]
49. Reliable PPG-based algorithm in atrial fibrillation detection
50. Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.